Our study highlights the important role of the S100A4/NF-κB/MMP9 signaling axis in promoting lung cancer invasive capacity, and demonstrates that S100A4 overexpression associates with reduced overall survival among patients with lung adenocarcinoma. The gene discussed is S100A4; the disease is lung carcinoma.